These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16677425)

  • 21. Vasopressin analogues and V1a receptor agonists in septic shock.
    Maybauer MO; Maybauer DM
    Inflamm Res; 2011 May; 60(5):425-7. PubMed ID: 21312051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock.
    Bauer SR; Sacha GL; Lam SW; Wang L; Reddy AJ; Duggal A; Vachharajani V
    J Intensive Care Med; 2022 Jan; 37(1):92-99. PubMed ID: 33251906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
    Rehberg S; Enkhbaatar P; Traber DL
    Crit Care; 2009; 13(4):178. PubMed ID: 19691818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB; Ashton RC; Landry DW; Townsend RN
    J Trauma; 1999 Oct; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous arginine vasopressin infusion in refractory vasodilatory shock: a clinical study.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian J Pediatr; 2012 Apr; 79(4):488-93. PubMed ID: 21922300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study.
    Rodríguez-Núñez A; López-Herce J; Gil-Antón J; Hernández A; Rey C;
    Crit Care; 2006 Feb; 10(1):R20. PubMed ID: 16469127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin in sepsis and septic shock.
    Kampmeier TG; Rehberg S; Westphal M; Lange M
    Minerva Anestesiol; 2010 Oct; 76(10):844-50. PubMed ID: 20935620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arginine vasopressin for the treatment of septic shock in adults.
    Bauer SR; Lam SW
    Pharmacotherapy; 2010 Oct; 30(10):1057-71. PubMed ID: 20874043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Lam SW; Bauer SR; Cha SS; Oyen LJ
    Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
    Lauzier F; Lévy B; Lamarre P; Lesur O
    Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study.
    Rios DR; Kaiser JR
    J Pediatr; 2015 Apr; 166(4):850-5. PubMed ID: 25641242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant vasopressin and hydrocortisone therapy on short-term hemodynamic effects and vasopressor requirements in refractory septic shock.
    Buckley MS; MacLaren R
    J Crit Care; 2017 Dec; 42():6-11. PubMed ID: 28647651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arginine vasopressin in vasodilatory shock: a new therapy approach?].
    Dünser M; Wenzel V; Mayr AJ; Hasibeder WR
    Anaesthesist; 2002 Aug; 51(8):650-9; discussion 659-60. PubMed ID: 12391525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants.
    Holler B; Omar SA; Farid MD; Patterson MJ
    Pediatrics; 2004 Jun; 113(6):e608-16. PubMed ID: 15173544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
    Jochberger S; Dörler J; Luckner G; Mayr VD; Wenzel V; Ulmer H; Morgenthaler NG; Hasibeder WR; Dünser MW
    Crit Care Med; 2009 Feb; 37(2):476-82. PubMed ID: 19114902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.
    Rosenzweig EB; Starc TJ; Chen JM; Cullinane S; Timchak DM; Gersony WM; Landry DW; Galantowicz ME
    Circulation; 1999 Nov; 100(19 Suppl):II182-6. PubMed ID: 10567301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.